Prelude Capital Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,000
| Closed | -$3.13K | – | 1002 |
|
|
2025
Q1 | $3.13K | Hold |
11,000
| – | – | ﹤0.01% | 1050 |
|
|
2024
Q4 | $6.45K | Hold |
11,000
| – | – | ﹤0.01% | 1045 |
|
|
2024
Q3 | $4.91K | Sell |
11,000
-6,936
| -39% | -$3.09K | ﹤0.01% | 1133 |
|
|
2024
Q2 | $47.5K | Sell |
17,936
-5,731
| -24% | -$15.2K | ﹤0.01% | 1053 |
|
|
2024
Q1 | $64.8K | Sell |
23,667
-7,755
| -25% | -$21.2K | ﹤0.01% | 1126 |
|
|
2023
Q4 | $76.4K | Sell |
31,422
-500
| -2% | -$1.22K | 0.01% | 917 |
|
|
2023
Q3 | $64.5K | Buy |
31,922
+3,200
| +11% | +$6.46K | ﹤0.01% | 885 |
|
|
2023
Q2 | $84.7K | Sell |
28,722
-14,235
| -33% | -$42K | 0.01% | 826 |
|
|
2023
Q1 | $107K | Sell |
42,957
-19,765
| -32% | -$49.4K | 0.01% | 850 |
|
|
2022
Q4 | $199K | Buy |
62,722
+1,500
| +2% | +$4.76K | 0.01% | 840 |
|
|
2022
Q3 | $182K | Buy |
61,222
+29,422
| +93% | +$87.5K | 0.01% | 1066 |
|
|
2022
Q2 | $97K | Buy |
31,800
+20,800
| +189% | +$63.4K | ﹤0.01% | 1212 |
|
|
2022
Q1 | $149K | Buy |
+11,000
| New | +$149K | ﹤0.01% | 1054 |
|
|
2021
Q4 | – | Sell |
-10,400
| Closed | -$98K | – | 1596 |
|
|
2021
Q3 | $98K | Buy |
+10,400
| New | +$98K | ﹤0.01% | 1151 |
|